The builder for evidence-based investing

Build a strategy. Test it on real history. See the evidence.

Global Quality MomentumPublic
StrategyBenchmark · MSCI World
20102014201820222026
CAGR
+11.8%
Max drawdown
−23.4%
Sharpe ratio
0.91
History
16 yrs
Backtest 2010-01 → 2026-06 · run 2026-07-18Explore this strategy →

01 · Build

Build a Strategy

Screeners pick the assets. Rules set allocation and risk. Every rule visible.

Explore the Strategy Builder →
1

Screeners define the universe. 38,042 instruments in, 412 out — re-screened at every rebalance.

2

Allocation follows a method. Weights you can read, not guesses.

3

Risk is a rule, not a feeling. De-risk conditions and position exits, applied across the whole backtest.

Screening
Narrow the universe down to what you'll trade
Chg Highest 20P/E < 30ROIC > 12%
38,042412match today

02 · Simulate

Run a Simulation

Your rules, replayed day by day through real market history. Costs and all.

Explore Backtesting →
Global Quality MomentumBACKTESTRisk-On
1Y5Y10YMax
StrategyBenchmark · MSCI World
20102014201820222026
Drawdownmin −23.4% · Aug 2022
Final value
€63,010
from €10,000 invested Jan 2010
CAGR
+11.8%
+3.9% vs benchmark
Max drawdown
−23.4%
benchmark −33.7% — 10.3% shallower
Volatility
14.2%
annualized
Backtest 2010-01 → 2026-06 · run 2026-07-18Rebalances and transaction costs included · Backtests show what would have happened — not what will.Explore this backtest →
1

Real market data. The simulation replays actual prices, day by day — no synthetic curves.

2

Costs are part of the result. Every rebalance and its transaction costs are in the numbers.

3

Drawdowns stay visible. What you'd have endured, not just what you'd have made.

03 · Analyze

Study the Analysis

Is it real, or luck? Every view exists to answer that question.

Explore Analysis →
Monthly ReturnsStart-Date SensitivityCapital Growth+4 views
Monthly Returns
Every month on the record — the red ones too
JFMAMJJASONDYr
2021+18.2%
2022−14.6%
2023+21.4%
2024+13.1%
2025+9.7%
Backtest 2010-01 → 2026-06 · run 2026-07-18
Start-Date Sensitivity
CAGR from every start date — windows of 1, 3, 5, 7 and 10 years
1 yr
3 yrs
5 yrs
7 yrs
10 yrs
CAGR per windowworst → best · avg tick
+11.4%avg CAGR across all windows · worst 10-yr start +8.4%
Drawdownmin −23.4%
1

Every month on the record. The heatmap hides nothing — 2022 stays red.

2

Move the start date. Every 1-to-10-year window on the record — one lucky start can't carry the result.

3

Consistency, not one good run. The longer the window, the tighter the CAGR spread — edge, not luck.

04 · Hold

See your Portfolio

The output isn't a chart. It's the exact portfolio your rules would hold today.

Explore Portfolio →
1

A portfolio, not a signal. Exact instruments and weights — nothing to decode.

2

Rebalance day is explicit. The rules say what changes; the account stays yours. Fincanva holds no money.

3

Always current. Screens and weights refresh on schedule, at market data.

Holdings today
Exact instruments, exact weights — 12 positions · as of 2026-07-18
TickerInstrumentWeight
AAPLApple Inc.
14.2%
MSFTMicrosoft Corp.
12.1%
NVDANVIDIA Corp.
11.0%
ASMLASML Holding NV
9.1%
LLYEli Lilly & Co.
8.3%
+ 7 more positions · 4.1% cash
Positions
12
Cash
4.1%
Top 5
54.7%
Risk
On

The glass box

No advice.
No magic.
Just evidence.

See every rule.

Every screener, weight and threshold in a strategy is inspectable. Nothing decides in the dark.

See every result.

Every backtest is dated, includes its costs, and can be re-run. Evidence you can check, not claims.

You decide.

Fincanva holds no money and gives no advice. The strategy is yours; so is the decision.

Backtests show what would have happened — not what will.

Coverage & method

Rigor you can count.

No track record, no testimonials — the dataset and the method are the proof.

38,042
instruments across equities, ETPs and crypto
64+
years of daily market history
118
screening filters, fundamental and technical
19
exchanges across 12 countries

Costs in every number.

Transaction costs are applied at every rebalance — results are net, not best-case.

Day-by-day replay.

Simulations step through the actual daily record — no interpolation, no synthetic data.

Published method.

What the simulation models — and what it can't — is documented in the open.

Dataset as of 2026-07-18 · methodology v1 · Read the methodology →

Pricing

Start free. Pay for capability.

Screeners, backtesting and one strategy are free. Paid tiers unlock more strategies and more sophisticated allocation.

Free
For exploring an idea
€0
1 active strategy
All screeners, full universe
Backtesting on full history
Core analysis views
Builder
For serious strategy research
€12/ month
Unlimited strategies
All allocation methods
All 7 analysis views
Rebalance alerts
Portfolio
For running the whole book
€29/ month
Everything in Builder
Combined strategies
Two-tier allocation
Portfolio view across strategies
No credit card to start · Cancel anytimeCompare all plans →

Build your first strategy.

Free to start. No credit card.